Drug policy in China. Transformations, current status and future prospects

Area of Science:

• Pharmaceutical industry
• Health economics
• Market analysis

Background:

• China's pharmaceutical sector experienced rapid growth post-1970s economic reforms, with drug production quadrupling between 1980-1988.
• The number of pharmaceutical companies, including private joint ventures, significantly increased, contributing to market expansion.
• Emerging issues include low efficiency, drug quality concerns, unfair competition, and drug misuse, despite government countermeasures.

Purpose of the Study:

• Analyze the growth trajectory of China's pharmaceutical market.
• Identify key factors driving and hindering pharmaceutical market development in China.
• Examine the opportunities and challenges facing pharmaceutical companies in the evolving Chinese landscape.

Main Methods:

• Analysis of historical pharmaceutical production and consumption data.
• Review of market reforms and their impact on the pharmaceutical sector.
• Assessment of demographic, economic, and policy factors influencing drug demand.

Main Results:

• Rapid expansion of drug production and consumption, fueled by market reforms and increased company numbers.
• Persistent challenges related to operational efficiency, drug quality, and market practices.
• Conflicting trends influencing future demand: demographic shifts and economic growth versus cost-containment health reforms.

Conclusions:

• China's pharmaceutical market faces a dynamic future with both growth opportunities and potential downturns.
• The interplay between factors increasing drug demand and cost-control measures will shape market trends.
• Effective implementation of health reforms could lead to reduced drug demand, impacting market expansion.